Abstract
We have previously shown that estradiol-17β (E2) will induce a pituitary luteinizing hormone (LH) surge in postmenopausal women. The current study was designed to evaluate dose response of progesterone (P) on the initiation, augmentation, or inhibition of pituitary LH release in postmenopausal women. Nine healthy postmenopausal women were administered transdermal E2, 0.05 mg per day for 1 week, followed by 0.20 mg per day for 3 days. In a random assignment, the volunteers each were given one of the three doses of P (12.5, 25.0, and 50.0 mg intramuscularly) daily during the 0.20-mg estrogen administration. There was a washout period of 2 weeks between each of the three P treatment regimens. A pituitary LH surge was induced in five volunteers with all three regimens. The mean time to the initiation of the LH surge was 0.55 ± 0.32 days, the peak LH value was found after 0.99 ± 0.39 days, and the duration of the surge was 1.40 ± 0.56 days. These data suggest that P advances the LH surge following estrogen priming in postmenopausal women. The dose of administered P did not result in any other changes in pituitary LH release.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
